Printer Friendly

Articles from Contract Pharma (May 1, 2013)

1-53 out of 53 article(s)
Title Author Type Words
3 (d) the third dimension: limit the verdict to Glivec. Harachand, S. 807
AcceIrys expands LIMS Suite: ATMI introduces fill/finish SU platform. 928
ACM Global appoints clinical Ops VP. 176
Almac Discovery licenses cancer drug. 112
Annual outsourcing survey. Survey 2451
Aptiv Solutions establishes Adaptive CoE. 225
Averica Discovery, WPI in research pact. 171
Bilcare Research expands manufacturing capabilities. 143
Biosimilar approaches: how to best outsource the development of biosimilars. DiPaola, Mario 1172
BMS names quintiles preferred provider: Covance expands Singapore central lab. 165
Catalent appoints China JV heads: Teva names global BD EVP. 1740
Catalent opens Bio-CoE: DSM to open bio-site in Brisbane. 278
CenterWatch study rates CROs. 212
Cognex announces VisionView 900 ID system. 198
Compounding the compounding problem: FDA seeks out high-risk pharmacies. Silverman, Ed 1406
Contract packaging update: serialization transforms the business. Roth, Gil 1879
Covance expands Singapore central lab. 188
CROs and innovative leadership: Parexel's CEO talks about the MassBio award and the digital future. Roth, Gil Y. Interview 1668
DSM to open Brisbane Bio-Mfg. Ops. 173
DSM, DecImmune in antibody pact: AMRI, Ono expand drug discovery pact. 1616
EMD Serono expands U.S. R&D presence. 189
Evotec expands East Coast capabilities. 129
Fujifilm Diosynth commissions Cell Banking Facility. 174
Goodwin, Coldstream in ADC Alliance. 130
Hardy diagnostics launches Media-Fill Challenge Kits. 176
How to live on $125 a day: plus: Alzheimer's R&D--in or out? Roth, Gil 746
ICON, UCD launch Business Academy. 160
Industry events. Calendar 369
Integrated providers: vertical integration & turnkey contract manufacturing. Cox, Byran Company overview 2213
inVentiv, Bell Medical in strategic pact. 134
Labeling on Ferrules and Cap Overseals: what drugmakers need to know about the revised USP General Chapter <1> Injections standard. Mooney, Carol 1445
Ligand acquires bio-portfolio from Selexis. 173
Merck, Pfizer form diabetes pact: PAREXEL acquires HERON Group. 220
Metrics offers new taste masking technology. 127
More scrutiny for cGMP violations: DOJ to pursue enforcement. Banuelos, Heather 1516
More transparency: why not in pricing drugs? Martorelli, Michael A. 760
On your own: the successful employee-to-consultant transition. Cohen, Jack 1466
Outsourcing preclincial and clinical work: focus on quality! Karu, K.R. 998
PAREXEL acquires HERON. 149
Pfenex awards glide formulation contract. 229
Pharma's R&D productivity engine: enabling technologies for leveraging big data. Jawadekar, Mak 889
PPD expands cGMP assay Lab. 104
Risk and compliance management: a painful manual process improving with automation. Schwartz, Jeff 1250
SCM to support BTG NDA. 169
Selecting a central laboratory: algorithms can reduce the role of subjective factors. Karelin, Andrei; Belotserkovskiy, Maxim; Khokhlova, Veronika; Kumar, Akhil 2345
SPR & flow cytometry for biosimilars: evaluating the pharmacodynamics of biosimilar monoclonal antibodies. Hulse, James; Cox, Chris 2807
Theravance Splits Assets: metrics offers new taste masking technology. 247
UPS to acquire CEMELOG. 191
Vax fix: OIG report forces overhaul of states' child vax programs. O'Donnell, Kevin 1267
Water Street invests in CCBR-SYNARC. 286
What does this compound do? One question, many answers. Lowe, Derek B. 1247
What is EXCiPACT? Learn about excipient supplier certification. Moore, Iain Interview 774
Working with CPOs: contract packaging becomes a competitive advantage. Grimm, Edward 904

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |